INFLUENCE OF PHARMACOLOGICAL CORRECTION ON THE QUALITY OF LIFE OF CHILDREN WITH FUNCTIONAL DYSPEPSIA
Abstract
Objective: To study the influence of pharmacological psychocorrection with drugs derived from GABA on the quality of life of primary school-aged children with functional dyspepsia.
Materials and methods. 80 children aged 6–12 years with FD have been examined. Children were divided into 4 groups: Group 1 – 20 patients who received γ-amino-β-phenylbutyric acid hydrochloride along with baseline therapy, Group 2 – 20 patients who received comprehensive treatment and calcium hopantenate, Group 3 – 20 children who received vitamin-mineral complex and protocol treatment, and Control Group – 20 children who received baseline treatment. Study Design: general clinical, instrumental, psychodiagnostic, statistical.
Results. Using the PedsQL questionnaire, physical functioning disorders were found in children with FD – 97.5±1.2 % (78/80) of children, emotional functioning disorders – 91.3±1.6 % (73/80) of cases, functioning at school disorders – 88.8±2.7 % (71/80) of patients. During one-month case monitoring, children who took GABA drugs reported an improvement in the quality of life compared with baseline treatment and a group of children, who took a mineral-vitamin complex: physical functioning – (р1=0,016), (р2=0,03), emotional functioning – (р1˂0,001), (р2˂0,001), functioning in school – (р1=0,005), (р2=0,004).
Conclusion. The use of γ-aminobutyric acid drugs is safe and effective and they significantly improve the quality of life of children with FD.
Downloads
References
Maidannyk, V. H. (2016). Rome IV criteria (2016): what’s new? International Journal of Paediatrics, Obstetrics and Gynaecology, 6 (1), 8–18.
Drossman, D. A., Hasler, W. L. (2016). Rome IV – Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology, 150 (6), 1257–1261. doi: http://doi.org/10.1053/j.gastro.2016.03.035
Drossman, D. A. (2006). The Functional Gastrointestinal Disorders and the Rome III Process. Gastroenterology, 130 (5), 1377–1390. doi: http://doi.org/10.1053/j.gastro.2006.03.008
Ganesh, M., Nurko, S. (2014). Functional Dyspepsia in Children. Pediatric Annals, 43(4), e101–e105. doi: http://doi.org/10.3928/00904481-20140325-12
Klassen, A. F., Miller, A, Fine, S. (2004). Health-Related Quality of Life in Children and Adolescents Who Have a Diagnosis of Attention-Deficit/Hyperactivity Disorder. Pediatrics, 114 (5), e541–e547. doi: http://doi.org/10.1542/peds.2004-0844
Constitution of the World Health Organization – Basic Documents (2006). World Health Organization. Available at: https://www.who.int/governance/eb/who_constitution_en.pdf
Rajindrajith, S., Zeevenhooven, J., Devanarayana, N. M., Perera, B. J. C., Benninga, M. A. (2018). Functional abdominal pain disorders in children. Expert Review of Gastroenterology & Hepatology, 12 (4), 369–390. doi: http://doi.org/10.1080/17474124.2018.1438188
Varni, J. W., Bendo, C. B., Nurko, S., Shulman, R. J., Self, M. M., Franciosi, J. P. et. al. (2015). Health-Related Quality of Life in Pediatric Patients with Functional and Organic Gastrointestinal Diseases. The Journal of Pediatrics, 166 (1), 85–90. doi: http://doi.org/10.1016/j.jpeds.2014.08.022
Hardman, M. I., Sprung, J., Weingarten, T. N. Acute phenibut withdrawal: A comprehensive literature review and illustrative case report. Bosnian Journal of Basic Medical Sciences, 19 (2), 125–129. doi: http://doi.org/10.17305/bjbms.2018.4008
On approval of unified clinical protocols of medical care for children with diseases of the digestive system (2013). Order of the Ministry of Health of Ukraine No. 59. 29.01.2013. Available at: https://zakononline.com.ua/documents/show/117384___531299
Khaitovych, M. V. (2016). GABA-ergic neuroprotection: clinical management. Drugs of Ukraine, 5, 84–86
Khaitovych, M. V. (2002). Cognitive impairment in children with autonomic dysfunction and their correction by Noofen. Paediatrics, Obstetrics and Gynaecology, 1-2 (197-198), 34–38.
Nahorna, N. V., Dubova, H. V., Bordiuhova, O. V., Muravska, I. Yu. Kyslytsia, V. M., Burka, O. O. et. al. (2012). The efficiency of noofen in correction of psychoemotional status of children with vegetativefvascular dysfunction. Modern Paediatrics, 7 (47), 47–51.
Zavadenko, N. N. (2005). School maladjustment in paediatric work. Attending Doctor, 5 (1). Available at: http://www.lvrach.ru/2005/01/4531954/
Liu, L., Li, C., Lu, Y., Zong, X., Luo, C., Sun, J., Guo, L. (2015). Baclofen mediates neuroprotection on hippocampal CA1 pyramidal cells through the regulation of autophagy under chronic cerebral hypoperfusion. Scientific Reports, 5 (1). doi: http://doi.org/10.1038/srep14474
Tiurenkov, I. N., Bahmetova, V., Borodkina, L. E., Berestovitskaia, V. M., Vasileva, O. S. (2012). Phenibut and its citrate in the prevention of psychoneurological disorders caused by chronic stress – deprivation of the paradoxical phase of sleep. Experimental and Clinical pharmacology, 75 (6), 8–13. Available at: http://ekf.folium.ru/index.php/ekf/article/view/304
Terunuma, M. (2018). Diversity of structure and function of GABAB receptors: a complexity of GABAB-mediated signaling. Proceedings of the Japan Academy, Series B, 94 (10), 390–411. doi: http://doi.org/10.2183/pjab.94.026
Tiurenkov, I. N., Samotrueva, M. A., Serezhnikova, T. K. (2011). GABA-ergic system and GABA drugs in the regulation of immunogenesis. Experimental and Clinical Pharmacology, 74 (11), 36–42. Available at: http://ekf.folium.ru/index.php/ekf/article/view/436
Team R Core. R: a language and environment for statistical computing (2013). R Foundation for Statistical Computing. Vienna.
Copyright (c) 2020 Marina Mamenko, Hanna Drokh
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our journal abides by the CREATIVE COMMONS copyright rights and permissions for open access journals.
Authors, who are published in this journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons Attribution License, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
